Body Mass Index as a Major Prognostic Contributing Factor in COVID-19: A Multicentral Egyptian Study

Background Extreme body mass index (BMI) is an influential pathophysiological risk factor for serious illnesses following lower respiratory tract infection. The purpose of the current study was to examine how the BMI of Coronavirus disease-19 (COVID-19) patients affects their prognosis. Methods Two hundred patients with COVID-19 admitted to Al-Azhar, Qena, Aswan, and Sohag University hospitals in Egypt were included and categorized into four groups according to their BMI. The diagnosis was made according to a real-time reverse transcription-polymerase chain reaction (rRT-PCR) positive result for the SARS-CoV-2 nucleic acid in swabs from upper respiratory tract. A detailed history, clinical examination, and outcomes (disease severity and complications, hospital stay, ICU admission, mortality) were recorded for all patients. SPSS version 24 software was used for data analysis. Results Average age of participants (19–90 years old), 92 (46%) males and 108 females (54%). ICU admission was significantly higher among underweight patients (75%) and obese patients (78.6%). The majority of underweight (62.5%) and obese (57.1%) patients had critical disease. Invasive mechanical ventilation (MV) is frequently used in underweight (50%) and obese patients (42.9%) patients. Adult respiratory distress syndrome (ARDS), cardiac, neurological, and hematological complications, and incidence of myalgia and bed sores were most frequent among obese and overweight patients. Acute kidney injury was significantly higher among underweight patients (37.5%) and obese patients (28.6%) than among other classes (p=0.004). Frequency of endocrine complications was significantly higher in underweight patients than that in other classes (p=0.01). The majority of underweight (75%) and obese patients (50%) deteriorated and died, whereas the majority of normal-weight patients (90.3%) and overweight patients (75.8%) improved and were discharged (p< 0.001). Conclusion Body mass index is a major contributing factor to the outcome of patients with COVID-19, and patients with extreme of body mass index were associated with the worst prognosis.

[1]  Shimaa A. Mahmoud,et al.  Outcome of Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19) patients , 2023, SVU-International Journal of Medical Sciences.

[2]  M. Abdelmotaleb Spontaneous pneumothorax and spontaneous pneumomediastinum in COVID-19 patients. , 2022, SVU-International Journal of Medical Sciences.

[3]  Aline Duarte de Souza,et al.  Avaliação do risco e estado nutricional em pacientes com Covid-19 hospitalizados , 2022, DEMETRA: Alimentação, Nutrição &amp; Saúde.

[4]  C. F. Leochico,et al.  Body mass index and its association with COVID-19 clinical outcomes: Findings from the Philippine CORONA study , 2022, Clinical Nutrition ESPEN.

[5]  M. Schaalan,et al.  The Impact of Sociodemographic, Nutritional, and Health Factors on the Incidence and Complications of COVID-19 in Egypt: A Cross-Sectional Study , 2022, Viruses.

[6]  Feng Pan,et al.  The association of obesity with the progression and outcome of COVID‐19: The insight from an artificial‐intelligence‐based imaging quantitative analysis on computed tomography , 2022, Diabetes/metabolism research and reviews.

[7]  Andinet B Gizaw,et al.  Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis , 2022, BMJ nutrition, prevention & health.

[8]  Lei Zhao,et al.  Both Underweight and Obesity Are Associated With an Increased Risk of Coronavirus Disease 2019 (COVID-19) Severity , 2021, Frontiers in Nutrition.

[9]  E. Ciolac,et al.  Determinants of endothelial dysfunction in noncritically ill hospitalized COVID‐19 patients: A cross‐sectional study , 2021, Obesity.

[10]  E. Abdelilah,et al.  Lymphopenia in Covid-19: A single center retrospective study of 589 cases , 2021, Annals of Medicine and Surgery.

[11]  A. Dosanjh,et al.  The risk of pressure ulcers in a proned COVID population , 2021, The Surgeon.

[12]  N. Desai,et al.  Association of obesity with venous thromboembolism and myocardial injury in COVID-19 , 2021, Obesity Research & Clinical Practice.

[13]  J. Bonventre,et al.  Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection , 2021, Nature Metabolism.

[14]  S. O’Rahilly,et al.  Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study , 2021, The Lancet Diabetes & Endocrinology.

[15]  J. Gameiro,et al.  The Weight of Obesity in Immunity from Influenza to COVID-19 , 2021, Frontiers in Cellular and Infection Microbiology.

[16]  H. Abdelkhalek,et al.  Neurological Diseases: Cause and Effect in the Era of COVID-19 , 2021, SVU-International Journal of Medical Sciences.

[17]  H. H. Chiu,et al.  The prevalence of malnutrition and analysis of related factors among adult patients with the Coronavirus Disease 2019 (COVID 19) in a tertiary government hospital: The MalnutriCoV study , 2021, Clinical Nutrition ESPEN.

[18]  H. Jia,et al.  High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study , 2021, BMC Infectious Diseases.

[19]  M. Jaeger,et al.  A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients , 2021, International Journal of Obesity.

[20]  Amal Fathi Gharib,et al.  Impact of Obesity and Its Associated Comorbid Conditions on COVID-19 Presentation , 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

[21]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[22]  G. Ahmed Managing Diabetic Patients during the Coronavirus Disease (COVID-19) Pandemic , 2020 .

[23]  H. Dupont,et al.  The association between body mass index class and coronavirus disease 2019 outcomes , 2020, International Journal of Obesity.

[24]  A. Hamdy,et al.  A Suggested Role of Human Growth Hormone in Control of the COVID-19 Pandemic , 2020, Frontiers in Endocrinology.

[25]  J. Hirsch,et al.  BMI as a Risk Factor for Clinical Outcomes in Patients Hospitalized with COVID‐19 in New York , 2020, Obesity.

[26]  Gang Wu,et al.  The importance of overweight in COVID-19 , 2020, Medicine.

[27]  C. Ayers,et al.  Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. , 2020, Circulation.

[28]  W. Ji,et al.  Impact of obesity, fasting plasma glucose level, blood pressure, and renal function on the severity of COVID-19: A matter of sexual dimorphism? , 2020, Diabetes Research and Clinical Practice.

[29]  B. Charra,et al.  Nutritional status assessment in patients with Covid-19 after discharge from the intensive care unit , 2020, Clinical Nutrition ESPEN.

[30]  H. Namkoong,et al.  Susceptibility of the obese population to COVID-19 , 2020, International Journal of Infectious Diseases.

[31]  N. Soetedjo,et al.  Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[32]  P. Huang,et al.  Obese COVID‐19 patients show more severe pneumonia lesions on CT chest imaging , 2020, Diabetes, obesity & metabolism.

[33]  A. Hussein,et al.  Is there a correlation between pulmonary inflammation index with COVID-19 disease severity and outcome? , 2020, medRxiv.

[34]  S. Czernichow,et al.  Obesity Doubles Mortality in Patients Hospitalized for Severe Acute Respiratory Syndrome Coronavirus 2 in Paris Hospitals, France: A Cohort Study on 5,795 Patients , 2020, Obesity.

[35]  Juping Yuan,et al.  Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics , 2020, International journal of molecular sciences.

[36]  P. Hegyi,et al.  Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysis , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[37]  Z. Xia,et al.  Obesity and mortality of COVID-19. Meta-analysis , 2020, Obesity Research & Clinical Practice.

[38]  M. Berger Nutrition Status Affects COVID‐19 Patient Outcomes , 2020, JPEN. Journal of parenteral and enteral nutrition.

[39]  S. Al-Youha,et al.  Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait , 2020, EClinicalMedicine.

[40]  A. Mohamed,et al.  Characteristics, Outcomes and Indicators of Severity for COVID-19 Among Sample of ESNA Quarantine Hospital’s Patients, Egypt: A Retrospective Study , 2020, Infection and drug resistance.

[41]  M. Aly,et al.  Indicators of Critical Illness and Predictors of Mortality in COVID-19 Patients , 2020, Infection and drug resistance.

[42]  C. Yanover,et al.  What Factors Increase the Risk of Complications in SARS-CoV-2–Infected Patients? A Cohort Study in a Nationwide Israeli Health Organization , 2020, JMIR public health and surveillance.

[43]  S. Hadjadj,et al.  Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study , 2020, Diabetologia.

[44]  R. Vettor,et al.  Obesity and COVID‐19: An Italian Snapshot , 2020, Obesity.

[45]  P. Vanhems,et al.  Prevalence of obesity among adult inpatients with COVID-19 in France , 2020, The Lancet Diabetes & Endocrinology.

[46]  Feng Gao,et al.  Obesity Is a Risk Factor for Greater COVID-19 Severity , 2020, Diabetes Care.

[47]  C. Mantzoros,et al.  Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York , 2020, Metabolism.

[48]  R. Arena,et al.  Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation , 2020, The American Journal of Medicine.

[49]  Norbert Stefan,et al.  Obesity and impaired metabolic health in patients with COVID-19 , 2020, Nature Reviews Endocrinology.

[50]  Tao Li,et al.  Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China , 2020, European Journal of Clinical Nutrition.

[51]  Iain B McInnes,et al.  Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. , 2020, Circulation.

[52]  R. José,et al.  Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome? , 2020, Obesity.

[53]  D. Mathieu,et al.  High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation , 2020, Obesity.

[54]  Lei Liu,et al.  Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China , 2020, Diabetes Care.

[55]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[56]  Wei Xu,et al.  Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  Wei Wang,et al.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.

[58]  Heshui Shi,et al.  Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet Infectious Diseases.

[59]  C. Zheng,et al.  Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia , 2020, Radiology.

[60]  C. Zheng,et al.  Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19) , 2020 .

[61]  L. Forni,et al.  Lung–kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup , 2019, Intensive Care Medicine.

[62]  S. Schultz-Cherry,et al.  Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution , 2019, Front. Immunol..

[63]  J. S. Lima Rodríguez,et al.  Risk factors for pressure ulcer development in Intensive Care Units: A systematic review. , 2017, Medicina intensiva.

[64]  Joshua A. Salomon,et al.  Health Effects of Overweight and Obesity in 195 Countries over 25 Years. , 2017, The New England journal of medicine.

[65]  Cheryl Newton,et al.  Body mass index and pressure ulcers: improved predictability of pressure ulcers in intensive care patients. , 2014, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[66]  M. Elia,et al.  ESPEN guidelines for nutrition screening 2002. , 2003, Clinical nutrition.

[67]  THE WORLD HEALTH ORGANIZATION , 1954 .

[68]  M. El-Dahshan,et al.  OUTCOMES OF COVID-19 IN EGYPTIAN PATIENTS , 2021, Al-Azhar Medical Journal.

[69]  C. Guérin,et al.  The impact of patient positioning on pressure ulcers in patients with severe ARDS: results from a multicentre randomised controlled trial on prone positioning , 2013, Intensive Care Medicine.

[70]  M. Kone,et al.  Infection and Drug Resistance , 2022 .